213 related articles for article (PubMed ID: 17065626)
1. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.
Rittenhouse S; Singley C; Hoover J; Page R; Payne D
Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626
[TBL] [Abstract][Full Text] [Related]
2. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
[TBL] [Abstract][Full Text] [Related]
3. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Vingsbo Lundberg C; Frimodt-Møller N
Int J Antimicrob Agents; 2013 Sep; 42(3):272-5. PubMed ID: 23837927
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
Kircik LH
J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
[TBL] [Abstract][Full Text] [Related]
6. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
Tarragó C; Esquirol LP; Arañó A; Lachamp L; D'Aniello F; Zsolt I
Future Microbiol; 2018 May; 13():21-30. PubMed ID: 29745240
[TBL] [Abstract][Full Text] [Related]
9. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
[TBL] [Abstract][Full Text] [Related]
10. Retapamulin (Altabax)--a new topical antibiotic.
Med Lett Drugs Ther; 2008 Feb; 50(1280):13-5. PubMed ID: 18292714
[No Abstract] [Full Text] [Related]
11. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
[TBL] [Abstract][Full Text] [Related]
12. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
[TBL] [Abstract][Full Text] [Related]
13. Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.
Traczewski MM; Brown SD
Antimicrob Agents Chemother; 2008 Nov; 52(11):3863-7. PubMed ID: 18725451
[TBL] [Abstract][Full Text] [Related]
14. Agents for the decolonization of methicillin-resistant Staphylococcus aureus.
McConeghy KW; Mikolich DJ; LaPlante KL
Pharmacotherapy; 2009 Mar; 29(3):263-80. PubMed ID: 19249946
[TBL] [Abstract][Full Text] [Related]
15. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
Weinberg JM; Tyring SK
J Drugs Dermatol; 2010 Oct; 9(10):1198-204. PubMed ID: 20941943
[TBL] [Abstract][Full Text] [Related]
16. Retapamulin: a newer topical antibiotic.
Dhingra D; Parakh A; Ramachandran S
J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP
Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study.
Tomayko JF; Li G; Breton JJ; Scangarella-Oman N; Dalessandro M; Martin M
Adv Skin Wound Care; 2013 Mar; 26(3):113-21. PubMed ID: 23426412
[TBL] [Abstract][Full Text] [Related]
20. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?
Moody MN; Morrison LK; Tyring SK
Skin Therapy Lett; 2010 Jan; 15(1):1-4. PubMed ID: 20066388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
